Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1;23(1):483.
doi: 10.3390/ijms23010483.

Gut Microbiota as a Source of Uremic Toxins

Affiliations

Gut Microbiota as a Source of Uremic Toxins

Vasily A Popkov et al. Int J Mol Sci. .

Abstract

Uremic retention solutes are the compounds that accumulate in the blood when kidney excretory function is impaired. Some of these compounds are toxic at high concentrations and are usually known as "uremic toxins". The cumulative detrimental effect of uremic toxins results in numerous health problems and eventually mortality during acute or chronic uremia, especially in end-stage renal disease. More than 100 different solutes increase during uremia; however, the exact origin for most of them is still debatable. There are three main sources for such compounds: exogenous ones are consumed with food, whereas endogenous ones are produced by the host metabolism or by symbiotic microbiota metabolism. In this article, we identify uremic retention solutes presumably of gut microbiota origin. We used database analysis to obtain data on the enzymatic reactions in bacteria and human organisms that potentially yield uremic retention solutes and hence to determine what toxins could be synthesized in bacteria residing in the human gut. We selected biochemical pathways resulting in uremic retention solutes synthesis related to specific bacterial strains and revealed links between toxin concentration in uremia and the proportion of different bacteria species which can synthesize the toxin. The detected bacterial species essential for the synthesis of uremic retention solutes were then verified using the Human Microbiome Project database. Moreover, we defined the relative abundance of human toxin-generating enzymes as well as the possibility of the synthesis of a particular toxin by the human metabolism. Our study presents a novel bioinformatics approach for the elucidation of the origin of both uremic retention solutes and uremic toxins and for searching for the most likely human microbiome producers of toxins that can be targeted and used for the therapy of adverse consequences of uremia.

Keywords: chronic kidney disease; microbiome; uremia; uremic toxins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Abundance of human mRNA expression in the whole organism: green lines—genes of uremic-retention-solutes-synthesizing enzymes.
Figure 2
Figure 2
Cluster heatmap representing a clustering of toxins according to bacteria that can potentially synthesize them. Color represents the number of enzymatic reactions in given bacteria that can potentially lead to the synthesis of a toxin (see Supplementary Figure S1 for a high-resolution version with all bacteria names expanded).

Similar articles

Cited by

References

    1. Levin A., Tonelli M., Bonventre J., Coresh J., Donner J.-A., Fogo A.B., Fox C.S., Gansevoort R.T., Heerspink H.J.L., Jardine M., et al. Global kidney health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888–1917. doi: 10.1016/S0140-6736(17)30788-2. - DOI - PubMed
    1. Jha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y.-M., Yang C.-W. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X. - DOI - PubMed
    1. Vanholder R., De Smet R., Glorieux G., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P.P., Deppisch R., et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–1943. doi: 10.1046/j.1523-1755.2003.00924.x. - DOI - PubMed
    1. Meyer T.W., Hostetter T.H. Uremia. N. Engl. J. Med. 2007;357:1316–1325. doi: 10.1056/NEJMra071313. - DOI - PubMed
    1. Lau W.L., Savoj J., Nakata M.B., Vaziri N.D. Altered microbiome in chronic kidney disease: Systemic effects of gut-derived uremic toxins. Clin. Sci. 2018;132:509–522. doi: 10.1042/CS20171107. - DOI - PubMed

LinkOut - more resources